{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-340449","form_type":"8-K/A","ticker":"COYA","cik":"0001835022","company_name":"Coya Therapeutics, Inc.","filed_at":"2026-08-07T21:00:14+00:00","discovered_at":"2026-08-07T21:02:02.438642+00:00","generated_at":"2026-08-07T21:02:24.356823+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Coya Therapeutics adds Mark Pavao to Audit Committee","bullets":["Mark H. Pavao appointed to Audit Committee effective Aug 6, 2026, on Board recommendation.","Audit Committee now comprises Dov Goldstein (Chair), Ann Lee, Dieter Weinand, and Mark Pavao.","Appointment follows Pavao's earlier board appointment effective April 1, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-340449","json":"https://secwatch.observer/filing/0001193125-26-340449.json","markdown":"https://secwatch.observer/filing/0001193125-26-340449.md","text":"https://secwatch.observer/filing/0001193125-26-340449.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526340449/0001193125-26-340449-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526340449/d177510d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-07T21:02:24.356823+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}